Aandeel 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Aandelen

002864

CNE1000032C9

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 13-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
29,94 CNY -0,03% Intraday-grafiek van Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -0,76% -22,21%
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd rapporteert resultaten voor het volledige jaar eindigend op 31 december 2023 CI
25/04 Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.
Panlong Pharmaceutical Plans 20 Million Yuan Share Buyback
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announces an Equity Buyback for CNY 20 million worth of its shares.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd authorizes a Buyback Plan.
Panlong Pharmaceutical Gets Sanitary License
Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Panlong Pharma Completes Registration of New Medical Clinic
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Approves Cash Dividend for 2022, Payable on May 31, 2023
Chinese Shares Retreat; Panlong Pharma Falls 7% on 302 Million Yuan Share Sale
Shaanxi Panlong Pharma Selling 302 Million Yuan Shares to Fund New Projects
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Proposes Final Cash Dividend for 2022
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Panlong Pharma Gets US Patent for Coronavirus Protease Inhibitor
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 002864
  4. Nieuws Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
  5. Andere talen